Search Results 291-300 of 16656 for anti-TNF drugs
The purpose of this study is to learn if the study drug, [225Ac]Ac-PSMA-R2, is safe and tolerable, and has anti-tumor activity in treated patients. Pagination ...
... medications (including but not limited to TNF-inhibitors. Correlate local levels of antigen with systemic levels measured in serum using matched patient ...
Individual interviews will be conducted. A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted ...
These are more common if you are female, have obesity, or have been taking anti-HIV medicines for a long time. Call your doctor right away if you have dark ...
The purpose of this study is to evaluate the utility of using anti-HLA antibody titer to measure the effectiveness of antibody lowering therapy (i.e., ...
About this study. This phase II trial tests how well nivolumab in combination with chemotherapy drugs along with radiation therapy works in treating ...
Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the ...
... anti-cancer drugs in patients with advanced solid tumors and gliomas. The study is divided into two parts: single agent FT-2102 followed by combination therapy.
Any biologic targeting immune response other than an anti-TNF within 12 weeks prior to screening endoscopy visit; Other advanced small molecule treatments ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Give by Dec. 31 to multiply your impact 3×.